Blockchain Registration Transaction Record
CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment on Promising Brain Cancer Therapy
CNS Pharmaceuticals participates in a Virtual Investor KOL Connect segment to discuss the urgent need for effective treatments in glioblastoma multiforme and the promising therapy, Berubicin. Learn more about the innovative cancer therapies offered by CNS Pharmaceuticals.
This news matters as it sheds light on the urgent need for effective treatments in glioblastoma multiforme and introduces Berubicin as a potential solution. Patients, investors, and the medical community can gain valuable insights into innovative cancer therapies for aggressive brain cancers.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xf64cf2128ee2bd150b16c88c7eb5ad45fe8e56341748e3c5431b98153415dca5 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | silkTZjn-7647509989f9e0f8e3412f64c9a519e3 |